ftc report pharmacy benefit managers - Search News

Pharmacy benefit managers inflated drug prices by $7.3B

USA Today · 23h

FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S.

The Wall Street Journal on MSN · 1d

Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says

The largest pharmacy-benefit managers hiked the prices of dozens of drugs dispensed through their own pharmacies, according to a new report by the Federal Trade Commission released on Tuesday.The markups helped the PBMs reap $7.

Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

FTC doubles down on PBM criticism in new report

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

policymed.com1d

Second Federal Trade Commission Report on Pharmacy Benefit Managers (PBM’s) Focuses on Specialty Generics

The Federal Trade Commission (FTC) released its second interim staff report “Specialty Generic Drugs a Growing Profit Center ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results